- Patent Title: Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
-
Application No.: US17246014Application Date: 2021-04-30
-
Publication No.: US11643388B2Publication Date: 2023-05-09
- Inventor: Dean Sheppard , William F. DeGrado , Aparna Sundaram , Hyunil Jo , Richard Beresis , Marc Adler
- Applicant: The Regents of the University of California , ShangPharma Innovation Inc.
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California,ShangPharma Innovation Inc.
- Current Assignee: The Regents of the University of California,ShangPharma Innovation Inc.
- Current Assignee Address: US CA Oakland; US CA South San Francisco
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Main IPC: C07C275/26
- IPC: C07C275/26 ; C07C275/24 ; A61P11/06 ; C07D205/04 ; C07D213/73 ; C07D217/02 ; C07D217/06 ; C07D239/84
Abstract:
Disclosed herein, inter alia, are inhibitors of alpha 2 beta 1 integrin and methods of using the same.
Public/Granted literature
- US20220411366A1 INHIBITORS OF ALPHA 2 BETA 1 INTEGRIN AND METHODS OF USE THEREOF Public/Granted day:2022-12-29
Information query
